Reckitt Benckiser stock holds steady after note tender update
Published on 08/21/2026 at 08:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Reckitt Benckiser Group plc (GB00B24CGK77) traded at $13.96 in OTC quote data on August 21, 2026, with a $41.914 billion market cap and a 52-week range of $58.67 to $90.71 on the same quote page.
The latest visible company event is the expiration and results of a tender offer and consent solicitation for Mead Johnson Nutrition Company notes due 2044, a debt-management move that followed the company's H1 2026 earnings season and pricing actions.
Debt cleanup stays in view
The most recent market snapshot also shows a $0.06 decline, or 0.43%, from the prior close, with only 350 shares changing hands in the delayed OTC line. That leaves the stock near a low-volume session while investors weigh a $10.11 trailing P/E and a $6.53 trailing EPS.
On the operating side, the same quote page puts trailing revenue at $14.2 billion and trailing net income at $3.2 billion. That combination implies a 22.40% profit margin, a level that looks stronger than many consumer-staples peers in a higher-cost backdrop.
Cash and valuation
Reckitt's balance-sheet snapshot shows $1.95 billion in cash, $3.0 billion in levered free cash flow, and debt-to-equity of 109.56%. The market is therefore still pricing the group as a cash-generative defensive name rather than a pure growth story.
A Bloomberg report on August 20, 2026 said European shares were flat as oil and inflation concerns offset a bond recovery, a backdrop that matters for household-goods names with pricing power. For Reckitt, the more relevant comparison is that its 2026 market cap and profitability metrics remain anchored by a relatively modest leverage profile and a 4.41% forward dividend yield on the quote page.
Dettol and Durex
Reckitt's portfolio spans Dettol, Durex, Gaviscon, Nurofen, Strepsils, and Enfamil, with each brand aimed at a different corner of health, hygiene, and infant nutrition. That mix is central to the group's defensive pitch because it blends everyday consumer demand with products that carry more resilient pricing.
The July 27, 2026 quote snapshot on Yahoo Finance lists an OTCQX delayed price of $66.00 for RBGPF and a market cap of $41.914 billion, while the August 21, 2026 market view shows $13.96 for RBGLY on OTC Markets with the same company identity. As of August 21, 2026, the latest quoted U.S. line remains the $13.96 level.
Fact box
Company: Reckitt Benckiser Group plc
ISIN: GB00B24CGK77
Ticker: RBGLY
Exchange: OTCQX
Price (as of August 21, 2026, 3:24 p.m. ET): $13.96 USD
Market cap: $41.914 billion (as of August 21, 2026)
Sector / Industry: Consumer Defensive / Household & Personal Products
Index membership: FTSE 100
More on Reckitt Benckiser stock
Reckitt Benckiser stock is backed by a $41.914 billion market cap, a 52-week range of $58.67 to $90.71, and trailing revenue of $14.2 billion. The share line at $13.96 was unchanged in the quoted session aside from a $0.06 daily move.
